Uroplasty to market I-STOP in US:
This article was originally published in Clinica
Minneapolis, Minnesota-based Uroplasty has secured exclusive US distribution rights to the I-STOP mid-urethral sling for six years, following an agreement with the product's French developer CL Medical (Lyon) to distribute distribution of the I-STOP(TM) in the US. Uroplasty already sells the I-STOP in the UK through its wholly-owned subsidiary based in Reading, Berkshire. According to Uroplasty, the I-STOP is the only monofilament polypropylene tape specifically designed for treating female stress urinary incontinence caused by lack of urethral support (urethral hypermobility).
You may also be interested in...
ARPA-H could be a solution to some of FDA’s long-running complaints about US clinical trial infrastructure, the agency's cancer chief says.
WM Partners acquires Vega plant-based nutrition brand from Danone with plans to leverage its operational experience to grow the brand and tap Vega’s distribution to expand market for its existing portfolio of brands.
Israeli-based start-up RealView received US FDA 510(k) clearance for its Holoscope-i holographic system used prior to and during interventional procedures.